; (4) the House should continue its oversight efforts, particularly ongoing investigations conducted by the House Committee on Energy and Commerce, to ensure that taxpayer dollars intended to combat opioid abuse are spent appropriately and efficiently; and (5) the House should collaborate with State, local, and tribal entities to develop a comprehensive strategy for addressing the opioid addiction crisis. 505. Policy statement on medical discovery, development, delivery, and innovation (a) Findings The House finds the following: (1) The Nation’s commitment to the discovery, development, and delivery of new treatments and cures has made the United States the biomedical innovation capital of the world for decades. (2) The history of scientific discovery and medical breakthroughs in the United States is extensive, including the creation of the polio vaccine, the first genetic mapping, and the invention of the implantable cardiac pacemaker. (3) Reuters ranked the United States Health and Human Services Laboratories as first in the world for innovation on its 2017 list of the Top 25 Global Innovators. (4) The United States leads the world in the production of medical devices, and the United States medical device market accounts for approximately 40 percent of the global market. (5) The United States remains a global leader in pharmaceutical research and development investment, has produced more than half of the world’s new molecules in the past decade, and represents the world’s largest pharmaceutical market, which is triple the size of the nearest rival, China. (b) Policy on medical innovation It is the policy of this concurrent resolution that— (1) the Federal Government should foster investment in health care innovation and maintain the Nation’s world leadership status in medical science by encouraging competition